SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC
Position in NBIX — Neurocrine Biosciences Inc
CIK 1446179
BALA CYNWYD, PA
Position in NBIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$239,663
-$15,411,563 QoQ
Shares Held
1,422
-98.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#572
of 768 holders
Holding Since
Dec 2020
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC holds $1,979,682 across 4 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (12.1% of the industry book) .
All Filings in NBIX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $239,663 | 1,422 | Shares | Sole | 2026-08-14 | |
| 2024-12-31 | $15,651,226 | 114,661 | Shares | Sole | 2025-02-14 | |
| 2024-06-30 | $508,690 | 3,695 | Shares | Defined | 2024-08-15 | |
| 2021-09-30 | $4,567,042 | 47,618 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $725,034 | 7,450 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $2,082,706 | 21,416 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $2,090,680 | 21,812 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||